{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:03:55Z","timestamp":1776405835083,"version":"3.51.2"},"reference-count":65,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1517\/13543784.9.4.841","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T14:59:02Z","timestamp":1115218742000},"page":"841-858","source":"Crossref","is-referenced-by-count":36,"title":["Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia"],"prefix":"10.1517","volume":"9","author":[{"given":"William E","family":"Heydorn","sequence":"first","affiliation":[{"name":"Associate Medical Director - CNS, Forest Laboratories, 909 Third Avenue, New York, NY 10022-4731, USA. William.Heydorn@FRX.COM"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"e_1_2_1_5_1","first-page":"553","article-title":"Statistical Manual of Mental Disorders, 4th edition (DSM-IV)","author":"FRANCES A","year":"1994","unstructured":"FRANCES A: Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). American Psychiatric Association (1994)553\u2013557.","journal-title":"American Psychiatric Association"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0037-7856(76)90006-8"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.136.10.1257"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.3928\/0048-5713-19870701-06"},{"key":"e_1_2_1_9_1","first-page":"66","article-title":"Insomnia","volume":"93","author":"BECKER PM","year":"1993","unstructured":"BECKER PM, JAMIESON AO, BROWN WD: Insomnia. Use of a decision tree to assess and treat. Postgrad. Med. (1993) 93:66\u201385.","journal-title":"Use of a decision tree to assess and treat. Postgrad. Med."},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03430110069030"},{"key":"e_1_2_1_11_1","unstructured":"WALSH JK ENGELHARDE CL: Trends in the pharma-cologic treatment of insomnia. J. Clin. Psychiatry (1992) 53\\(Suppl. 12):510\u2013517."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00435262"},{"key":"e_1_2_1_13_1","first-page":"121","article-title":"Rebound insomnia and rebound anxiety: a review","volume":"26","author":"KALES A","year":"1983","unstructured":"KALES A, SOLDATOS CR, BIXLER E, KALES J: Rebound insomnia and rebound anxiety: a review. Pharma-cology (1983) 26:121\u2013137.","journal-title":"Pharma-cology"},{"key":"e_1_2_1_14_1","unstructured":"MENDELSON WB: Medications in the treatment of sleep disorders. In: Psychopharmacology: the Third Generation of Progress. Meltzer HY Coyle JT Kopin IJ (Eds.) Raven Press New York USA (1987):163\u2013172."},{"key":"e_1_2_1_15_1","unstructured":"Approved labelling for Zaleplon (Sonata Wyeth-Ayerst): Physician's Desk Reference 54th Edition. (2000):3319\u20133323."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016224629614"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.1997.tb00324.x"},{"key":"e_1_2_1_18_1","unstructured":"\u2022\u2022An excellent overview of the in vitro and in vivo pharma-cology of zaleplon."},{"key":"e_1_2_1_19_1","unstructured":"DAY IP CLODY DE MONAGHAN MM ABEL MS DUSZA JP BEER B: Pharmacology of CL 284 846 a non-benzodiazepine sedative with reduced amnestic liability. Soc. Neurosci. (1992) 18:725(Abstract)."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245068"},{"key":"e_1_2_1_21_1","unstructured":"\u2022\u2022Results from discriminative stimulus studies with zaleplon."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00510-9"},{"key":"e_1_2_1_23_1","unstructured":"\u2022\u2022Results of a comparison of zaleplon and zolpidem in variousin vivo models."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199708000-00002"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199408000-00003"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0149-7634(85)90037-5"},{"key":"e_1_2_1_27_1","first-page":"75","article-title":"Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential? Eur","volume":"145","author":"GARRATT JC","year":"1988","unstructured":"GARRATT JC, GENT JP, FEELY M, HAIGH JRM: Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential? Eur. J. Pharmacol. (1988) 145:75\u201380.","journal-title":"J. Pharmacol."},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-3565(25)10339-X","article-title":"Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem","volume":"263","author":"PERRAULT G","year":"1992","unstructured":"PERRAULT G, MOREL E, SANGER DJ, ZIVKOVIC B: Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J. Pharmacol. Exp. Ther. (1992) 263:298\u2013303.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(93)90140-X"},{"key":"e_1_2_1_30_1","first-page":"667P","article-title":"An investigation of anti-convulsant tolerance to zolpidem in mice","volume":"95","author":"COX A","year":"1988","unstructured":"COX A, BOYLAND P, GENT JP, FEELY M: An investigation of anti-convulsant tolerance to zolpidem in mice. Br. J. Pharmacol (1988) 95:667P.","journal-title":"Br. J. Pharmacol"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988119801200405"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199511000-00009"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.430330107"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-081X(199904)20:3<171::AID-BDD169>3.0.CO;2-K"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/004982598239452"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(24)14921-5"},{"key":"e_1_2_1_37_1","unstructured":"\u2022Demonstration of the difference in metabolism of zaleplon in rats versus monkeys."},{"key":"e_1_2_1_38_1","first-page":"319","article-title":"Species comparison of in vitro and in vivo metabolism of CL 284,846, a non-benzodiazepine sedative\/hypnotic agent","volume":"11","author":"CHAUDHARY I","year":"1994","unstructured":"CHAUDHARY I, DEMAIO W, KANTROWITZ J: Species comparison of in vitro and in vivo metabolism of CL 284,846, a non-benzodiazepine sedative\/hypnotic agent. Pharm. Res. (1994) 11:319.","journal-title":"Pharm. Res."},{"key":"e_1_2_1_39_1","first-page":"670","article-title":"WHEELERS,TROY S: Rapid disappearance of zaleplon from breast milk after oral administration to lactating women","volume":"39","author":"DARWISH M","year":"1999","unstructured":"DARWISH M, MARTIN P, CEVALLOS W, TSE S, WHEELERS,TROY S: Rapid disappearance of zaleplon from breast milk after oral administration to lactating women. J. Pharmacol. (1999) 39:670\u2013674.","journal-title":"J. Pharmacol."},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(91)90039-Q"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1994.tb02002.x"},{"key":"e_1_2_1_42_1","unstructured":"\u2022Results from a Phase I pharmacokinetic\/pharmacodynamic study with zaleplon."},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-196607000-00035"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1159\/000117969"},{"key":"e_1_2_1_45_1","first-page":"483","article-title":"A repeated dose comparison of the side effects of five antihistamines on objective assessments of psychomotor perform-ance, central nervous system arousal and subjective appraisals of sleep and early morning behavior","volume":"28","author":"HINDMARCH I","year":"1978","unstructured":"HINDMARCH I, PARROTT AC: A repeated dose comparison of the side effects of five antihistamines on objective assessments of psychomotor perform-ance, central nervous system arousal and subjective appraisals of sleep and early morning behavior. Arzneimit-Forchung (Drug Research) (1978) 28:483\u2013486.","journal-title":"Arzneimit-Forchung (Drug Research)"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb11115.x"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90139-4"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00265947"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314858"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470060206"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198810000-00004"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00265843"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.3758\/BF03331551"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.171.3972.701"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00024.x"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1077(1998110)13:2 <S98::AID-HUP54>3.0.CO;2-1"},{"key":"e_1_2_1_57_1","first-page":"321","article-title":"Standardization in platform stabilometry being part of posturography","volume":"24","author":"KAPTEYN TS","year":"1983","unstructured":"KAPTEYN TS, BLES W, NJIOKIKTREN CJ, KOODE L, MASSEN CH, MOL JM: Standardization in platform stabilometry being part of posturography. Aggresso-logie (1983) 24:321\u2013326.","journal-title":"Aggresso-logie"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1995.tb01140.x"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1159\/000119177"},{"key":"e_1_2_1_60_1","first-page":"363","article-title":"O'HANLON JF: Effects of loratadine and cetirizine on actual driving and psychometric test performance and EEG during driving","volume":"42","author":"RAMAEKERS JG","year":"1992","unstructured":"RAMAEKERS JG, UITERWIJK MMC, O'HANLON JF: Effects of loratadine and cetirizine on actual driving and psychometric test performance and EEG during driving. Eurj Gun. Pharmacol. (1992) 42:363\u2013369.","journal-title":"Eurj Gun. Pharmacol."},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050144"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.1998.tb01003.x"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199816050-00001"},{"key":"e_1_2_1_64_1","unstructured":"\u2022\u2022Results from a 14 day placebo-controlled multicentre studywith zaleplon in 132 patients."},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0806"},{"key":"e_1_2_1_66_1","unstructured":"\u2022\u2022Results from a 28 day placebo- and zolpidem-controlledstudy with zaleplon in 574 patients."},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(90)90009-W"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051030"},{"key":"e_1_2_1_69_1","unstructured":"\u2022An evaluation of the abuse potential of zaleplon in subjects with a history of drug abuse."}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.9.4.841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:11:28Z","timestamp":1770916288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.9.4.841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1517\/13543784.9.4.841"],"URL":"https:\/\/doi.org\/10.1517\/13543784.9.4.841","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}